These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9496259)

  • 1. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours.
    Abeln EC; Smit VT; Wessels JW; de Leeuw WJ; Cornelisse CJ; Fleuren GJ
    J Pathol; 1997 Dec; 183(4):424-31. PubMed ID: 9496259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.
    Jin Z; Ogata S; Tamura G; Katayama Y; Fukase M; Yajima M; Motoyama T
    Int J Gynecol Pathol; 2003 Oct; 22(4):368-73. PubMed ID: 14501818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
    Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelotype of papillary serous peritoneal carcinomas.
    Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
    Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
    Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
    J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.
    Obermann EC; Diss TC; Hamoudi RA; Munson P; Wilkins BS; Camozzi ML; Isaacson PG; Du MQ; Dogan A
    J Pathol; 2004 Feb; 202(2):252-62. PubMed ID: 14743509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.
    Buza N; Tavassoli FA
    Int J Gynecol Pathol; 2009 Nov; 28(6):514-21. PubMed ID: 19851197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors.
    Emerson RE; Wang M; Roth LM; Zheng W; Abdul-Karim FW; Liu F; Ulbright TM; Eble JN; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):368-74. PubMed ID: 17885485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of heterozygosity on chromosomes 7 and 9 in benign epithelial ovarian tumours.
    Roy WJ; Watson RH; Hitchcock A; Campbell IG
    Oncogene; 1997 Oct; 15(17):2031-5. PubMed ID: 9366520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
    McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
    J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary peritoneal malignant mixed Müllerian tumors. A clinicopathologic, immunohistochemical, and genetic study.
    Shen DH; Khoo US; Xue WC; Ngan HY; Wang JL; Liu VW; Chan YK; Cheung AN
    Cancer; 2001 Mar; 91(5):1052-60. PubMed ID: 11251959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.
    Jones TD; Eble JN; Wang M; Maclennan GT; Jain S; Cheng L
    Cancer; 2005 Sep; 104(6):1195-203. PubMed ID: 16047350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.
    Cooke IE; Shelling AN; Le Meuth VG; Charnock ML; Ganesan TS
    Genes Chromosomes Cancer; 1996 Apr; 15(4):223-33. PubMed ID: 8703848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascitic fluid cytology of a malignant mixed Müllerian tumor of the peritoneum: a report of two cases with special reference to p53 status.
    Kato N; Motoyama T
    Diagn Cytopathol; 2009 Apr; 37(4):281-5. PubMed ID: 19217035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.